Background: Differentiating lower airway bacterial infection from possible upper airway
| INTRODUCTION
Accurately identifying bacteria originating from the lower airways in patients with known or suspected chronic endobronchial infection is important in clinical practice and research. Its utility includes determining whether infection is indeed present, helping to guide antibiotic choices, and identifying the microbiological impact of novel therapies and vaccines. While sputum specimens are used for these purposes in adults, bronchoalveolar lavage (BAL) is employed in those who are unable to expectorate, such as young children 1 and mechanically ventilated adults. 2 However, as contamination from the upper airways often occurs, quantitative culture for BAL 1,2 is usually employed when bacteria are identified.
Despite the widespread use of quantitative BAL culture, the threshold density of bacteria used to diagnose infection varies. In a study involving both adults with a clinical diagnosis of lower airway infection and healthy controls, quantitative bacterial culture of BAL fluid was found to be 100% specific for infection using a threshold value for positive cultures of 10 4 colony-forming units (CFU)/mL. Determining the appropriate diagnostic threshold in clinical practice is complex and it is not feasible to undertake a randomized controlled study where the decision to treat is determined solely by BAL microbiologic data. A prospective, observational study involving infants and young children with CF examined associations between bacterial load (determined by serial BAL dilutions) and inflammatory markers (total and differential cell counts and interleukin (IL)-8 concentrations) and established that a threshold ≥10 5 CFU/mL should be used in children with CF. 1 This recommendation was supported by subsequent BAL-based studies in young CF children examining inflammatory responses within the lower airways to varying densities of different microorganisms. 11, 12 Although one of these studies included control children with other chronic respiratory problems (some had chronic cough), 11 no other published studies in children have systematically evaluated inflammatory indices associated with different bacterial loads in children without CF. 13 Our earlier study in children with bronchiectasis described significantly elevated inflammatory markers when nontypeable
Haemophilus influenzae bacterial load (determined by quantitative culture) exceeded 10 4 CFU/mL (versus ≤10 4 CFU/mL). 14 However, associations with lower and higher thresholds were not examined and the other two main respiratory pathogens in pediatric bronchiectasis, Streptococcus pneumoniae, and Moraxella catarrhalis, were not investigated. Further, the associations between bacterial load and inflammatory markers in children with chronic suppurative lung disease (CSLD) or protracted bacterial bronchitis (PBB) are also unknown. PBB, CSLD, and bronchiectasis are believed to form a continuum of chronic endobronchial disorders of increasing severity. 15 We, therefore, examined total cell counts (TCCs) and neutrophil counts associated with bacterial load in 655 children with these chronic endobronchial disorders, and 67 disease controls, to determine the appropriate threshold to define infection. IL-8 concentrations in BAL fluid were measured in a small subset of children with CSLD/ bronchiectasis. Based on our previous study, 14 Flexible bronchoscopy was performed under general anesthesia as described previously and when the child was not acutely unwell. 9, 10 BAL fluid was obtained from the most abnormal lobe(s), as seen on HRCT scan or during bronchoscopy, in accordance with international guidelines. 18 BAL fluid from the first lavage was placed on ice and sent to the laboratory where it was plated within 2 h for bacterial culture at RCH. At RDH, 0.5 mL BAL aliquots were transferred to cryovials containing 0.5 mL of concentrated skim-milk tryptone glucose glycerol broth (STGGB) and stored at −80°C; these were thawed subsequently and processed, and respiratory pathogens isolated and identified, as described previously. 6 
| Laboratory methods
Quantitative BAL culture based on serial dilutions is labor intensive and not offered by many laboratories as routine practice. 13 10 Rhinoviruses and human coronaviruses were tested in a subset of children.
Determination of total and differential cell counts was performed on the second lavage as described previously using a standardized method. (>400 × 10 3 cells/mL), airway neutrophilia (neutrophils >15% BAL leukocytes) 21 and high IL-8 concentrations (>250 pg/mL). 22 Variables significant in univariate analyses (P < 0.05) were included in multivariable analysis. Bacterial load was included as an ordinal variable.
| Reference values
In the absence of universal agreement on pediatric BAL reference values, we defined the above study-specific thresholds to help differentiate our results from age-matched "normal" children or other controls. Values from five studies of BAL cellularity in children who underwent bronchoscopy for various clinical indications, excluding respiratory tract infections, or surgery for non-pulmonary or noninflammatory conditions, were collated by a European Respiratory Society Task Force. 18 Neutrophil percentages ranged from 0% to 3% in two studies and 0% to 17% in two studies, and a fifth study reported interquartile range (IQR) 0.6-3.5%. 18 For this study we retained our prior definition of airway neutrophilia as >15%. 21 In the earlier CF study, GMs of TCCs and neutrophils for control, negative and low growth cultures were 115-170 × 10 3 and 3-25 × 10 3 cells/mL, respectively, and GMs of IL-8 concentrations were 27-100 pg/mL. 1 Our definitions of high TCC (>400 × 10 3 cells/mL) and high IL-8 concentrations (>250 pg/mL) are more than twice the upper limit of these values.
3 | RESULTS
| Study populations
NT children (n = 257) were enrolled from July 2007 to August 2016
and Qld children (n = 398, plus an additional 67 disease controls) were enrolled from July 2008 to August 2016 ( Table 1 ). The median ages of the cohorts were similar, although subgroups within the cohorts differed in age and Indigenous status. In those with bronchiectasis, NT children were younger and mostly Indigenous compared to Qld children. The cohorts also differed in their recent antibiotic exposure; 52% of NT children had received macrolide antibiotics (mostly azithromycin) in the 2-weeks preceding bronchoscopy, compared to 7% of Qld children. Most children in both cohorts (96% NT, 88% Qld) had received two or more doses of a pneumococcal conjugate vaccine.
| Bacterial pathogens
H influenzae, cultured from 398/655 (61%) BAL samples, was the dominant pathogen in children with chronic endobronchial disorders.
S pneumoniae was the next most prevalent pathogen, present in 184 (28%) samples, followed by M catarrhalis in 154 (24%) samples. S aureus and P aeruginosa were cultured less frequently in children with chronic endobronchial disorders, detected in 65 (10%) and 21 (3.2%) BAL samples respectively. In the 67 disease control children, S aureus was cultured from 15 (22%) children, followed by H influenzae (13, 19%), S pneumoniae (11, 16%), M catarrhalis (6, 9.0%), and P aeruginosa (1, 1.5%). Combined pathogen bacterial loads for NT and Qld children with PBB, CSLD, or bronchiectasis, and disease control children, are presented in Table 2 .
| Viruses
Data for the conventional panel of eight respiratory viruses (adenovirus, human metapneumovirus, influenza A and B, parainfluenza 1-3, and RSV) were available for 163 NT and 387 Qld cases, and 65 controls. At least one virus was detected in BAL samples from 26% of children with chronic endobronchial disorders when they were clinically stable compared to 14% of controls (Table 1) . Of 62 Qld children tested, rhinoviruses were detected in 17/50 (34%) with PBB or bronchiectasis and 2/12 (15%) controls, while human coronaviruses
were not detected in any of the BAL samples from these children. In 163 NT children with CSLD/bronchiectasis, rhinoviruses were detected in 41 (25%) and human coronaviruses in one child.
| Inflammatory markers
Airway cellularity data for all children with chronic endobronchial disorders and disease controls are presented in Table 3 . NT children with bronchiectasis had the highest TCCs (37% had >400 × 10 3 cells/mL) and Qld children with PBB had the highest neutrophil counts (78% had airway neutrophilia). The GM of IL-8 in 67 NT children with CSLD/bronchiectasis was 130 (95%CI 88-193) pg/mL; 23 (34%) children had IL-8 concentrations >250 pg/mL.
| Inflammatory markers versus bacterial load
GMs (with 95%CIs) of TCCs and neutrophil counts for all children with chronic endobronchial disorders, and disease controls, were plotted against bacterial loads for the combined five respiratory pathogens in 
| Factors associated with lower airway inflammation
In children with chronic endobronchial disorders, associations with high or low cell counts were not detected for age, sex or use of betalactam antibiotics (Table 4) (Table 4 ). Compared to ≥10 5 CFU/mL, a threshold of ≥10 4 CFU/mL had higher sensitivity, but lower specificity for all three markers of inflammation (Supplementary Table S1 ). Table S2 ).
| DISCUSSION
In 655 children with chronic endobronchial disorders, elevated TCC and airway neutrophilia were consistently associated with respiratory pathogen bacterial load ≥10 5 CFU/mL. These associations were seen by plotting GMs of cell counts against bacterial load and by using The relationship between lower airway infection and inflammation has been well established in PBB 16 and bronchiectasis. 9, 25 Similar data for pre-and post-antibiotic treatment are unsurprisingly limited in children as obtaining lower airway specimens is difficult in those who are either too young or unable to expectorate. In adults with bronchiectasis, treatment with antibiotics significantly reduced bacterial load and concomitant airway inflammation in a dosedependent manner. 25 Lower airway inflammation is a broad term that includes increased TCC, neutrophils and cytokines (eg, IL-8, free neutrophil elastase, matrix metalloproteinases, TNF-alpha) in lower airway specimens. [25] [26] [27] It is possible that employing more sensitive FIGURE 1 Paired airway cellularity and respiratory bacterial pathogen load data from 610 children with chronic endobronchial disorders, and 66 control children. CFU, colony-forming units; Neu, neutrophils; TCC, total cell count. Error bars represent 95% confidence intervals. Pathogens included any of H influenzae, S pneumoniae, M catarrhalis, S aureus, or P aeruginosa measures or a broader range of airway inflammatory markers may lead to a lower threshold. Nevertheless, a threshold ≥10 5 CFU/mL was established for infants with CF using similar indicators of inflammation to those used in our study. 1 Children were younger in the original CF study (mean age 17-months, range 1-52), the predominant pathogens were S aureus, P aeruginosa, and H influenzae, and 30 of the 150 BAL procedures were conducted in children hospitalized for an acute pulmonary exacerbation. 1 The elevations in cell counts seen in our study at 10 4 CFU/mL (not apparent in the CF study) 1 may be associated with S pneumoniae and/or M catarrhalis, two pathogens found less commonly in CF patients. Further, simultaneous colonization with S pneumoniae and H influenzae resulted in a synergistic proinflammatory response (increased production of IL-8, the major neutrophil chemokine in the airway) in vitro and in a mouse model. 28 An examination of pathogen-specific thresholds, and pathogenpathogen interactions in a larger cohort, may help to explain differences in inflammatory responses to bacterial load.
We found other factors, in addition to bacterial load, that were associated with increased TCC and/or neutrophilia. Indigenous children with chronic endobronchial disorders, particularly NT children with bronchiectasis (94% indigenous), had significantly higher TCCs than non-Indigenous children. The high prevalence of bronchiectasis in
Australian Indigenous children has long been recognized. 29 In Qld, only 6% of control children and 7.5% with PBB were Indigenous; however, 21% of children with bronchiectasis were Indigenous. This may represent evidence from another Australian setting that Indigenous children are more likely to progress to bronchiectasis. Alternatively, Indigenous children could be less likely to present early with symptoms of chronic endobronchial infection, and the finding that TCCs were higher in Indigenous compared to non-Indigenous children might reflect more advanced disease.
The presence of viruses also influenced airway cell counts as documented previously in children with wet cough and PBB. 10 Numerous synergistic virus-bacteria interactions have been documented, particularly between S pneumoniae and influenza virus and RSV. 30 Combinations of bacterial pathogens and respiratory viruses can enhance pathogen transmission and exacerbate disease development. 31 One of our study's limitations is that not all samples were tested for viruses; 85% of children had samples tested for the conventional panel of eight viruses, but only 31% were tested for human rhinovirus and coronavirus. There may, therefore, be residual confounding from unmeasured viruses, although the importance of rhinoviruses as pathogens in children is complicated by their presence in up to 45% of asymptomatic children when using sensitive molecular detection techniques. 32, 33 Differences in culture methods between Qld and NT laboratories represent another limitation. BAL specimens were plated within 2-hours of collection in Qld, whereas NT specimens were stored in STGGB at −80°C before being thawed and processed. However, we have shown that recovery of H influenzae, S pneumoniae, and M catarrhalis from nasopharyngeal swabs stored short-term in STGGB at −70°C is equivalent to direct plating of Amies swabs, 34 and these respiratory pathogens remain viable in frozen STGGB storage for at least 12 years. 35 Our finding of a statistically significant negative association between macrolide antibiotics and airway neutrophilic inflammation is consistent with a small Turkish randomized controlled trial, 27 which found that children receiving macrolides (compared to controls) had significantly reduced airway TCC, neutrophilia, and IL-8. Similar observations have been described in animal studies. 36 We also found a statistically significant reduction in lower airway bacterial load in children who received macrolide antibiotics. This reduction was not apparent in a smaller study of 104 Indigenous children with bronchiectasis. 37 However, macrolide antibiotics reduced nasopharyngeal carriage of respiratory bacterial pathogens in Indigenous children, 37, 38 and this was more pronounced when antibiotic use was frequent or long-term. 39 Indeed, a "cumulative dose-response" relationship was observed whereby increasing azithromycin exposure was associated with decreasing nasopharyngeal carriage of S pneumoniae, H influenzae, and M catarrhalis. 40 Our findings (in this larger study of 655 children) of a statistically significant reduction in respiratory bacterial pathogen load in BAL samples from children exposed to macrolide antibiotics may be showing a similar effect in the lower airways to that seen in the upper airways.
In conclusion, our findings support a threshold of ≥10 4 CFU/mL BAL to define lower airway infection in children with PBB, CSLD, or bronchiectasis. Associations with airway cellularity were stronger at ≥10 5 CFU/mL which may provide greater specificity in the setting of a clinical trial. However when compared to negative cultures, associations with high TCC and neutrophilia were consistently stronger at bacterial loads between 10 4 and 10 5 CFU/mL suggesting lower airway FIGURE 2 Paired airway cellularity and respiratory bacterial pathogen load data from 461 children with chronic endobronchial disorders, and 65 control children, who had not received macrolide antibiotics. Recorded as current antibiotics or taken <2-weeks preceding bronchoscopy. CFU, colony-forming units; Neu, neutrophils; TCC, total cell count. Error bars represent 95% confidence intervals. Pathogens included any of H influenzae, S pneumoniae, M catarrhalis, S aureus, or P aeruginosa infection is present. In contrast, there was no evidence of elevated inflammatory indices at bacterial load <10 4 CFU/mL. Finally, it is important to acknowledge that in clinical practice when interpreting bacterial culture results, the health of the patient, recent antibiotic exposure, inflammatory indices, and the nature of the pathogen should also be taken into account.
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